ARCHIVES

FDA Approves Kytril For Post-Operative Nausea

This article is from The Cancer Letter archive.

Vol. 25 No. 10 | October 25, 2002

Download PDF Visit The Full Archive

Related Articles

NCI Natural Product Drug Development To Get New Emphasis; Suggestions Of Critic Accepted

March 19, 1976

NCI-Approved Clinical Trials

March 31, 2006

Iniparib Doesn’t Meet Survival, PFS Endpoints In Phase III Trial in Triple-Negative Breast Cancer

February 25, 2011

NCAB Committee Approves Concepts For Recompetition Of CIDAC, Two Other Contracts

July 1, 1983

Drug Development Budget Cuts Force Early End To P388 Screening Contracts

January 9, 1987

ODAC Recommends Ethyol, DaunoXome For FDA Approval

June 16, 1995